United Therapeutics
UTHR
#1026
Rank
C$30.57 B
Marketcap
C$675.98
Share price
1.08%
Change (1 day)
29.25%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2025 (TTM): C$40.10

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$39.39. In 2024 the company made an earnings per share (EPS) of C$36.54 an increase over its 2023 EPS that were of C$29.09.

EPS history for United Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$40.109.74%
2024C$36.5425.59%
2023C$29.0931.54%
2022C$22.1251.18%
2021C$14.63-9.1%
2020C$16.09-581.4%
2019C-$3.34-117.79%
2018C$18.7942.11%
2017C$13.22-40.93%
2016C$22.3813.45%
2015C$19.73104.29%
2014C$9.66100.29%
2013C$4.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
C$28.35-28.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$9.01-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.87-97.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
C$2.38-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$0.91-102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C-$8.69-122.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$4.97-87.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
C$9.20-76.64%๐Ÿ‡บ๐Ÿ‡ธ USA